According to FutureWise analysis the market for blood screening in 2023 was US$ 2.94 billion, and is expected to reach US$ 5.6 billion by 2031 at a CAGR of 8.60%.

Blood screening is a vital process in medical diagnostics and transfusion medicine that involves testing blood samples to detect infections, diseases, and various health conditions. It plays a critical role in ensuring the safety of blood supplies, protecting both donors and recipients, and facilitating the early diagnosis and management of diseases in clinical settings.

In blood donation, screening is essential to prevent the transmission of infectious diseases through transfusions. Every unit of donated blood undergoes rigorous testing for bloodborne pathogens, including:

  • Human Immunodeficiency Virus (HIV)
  • Hepatitis B and C
  • Syphilis
  • Malaria
  • Human T-lymphotropic virus (HTLV)

In some regions, emerging infections like Zika virus and West Nile virus are also screened.

These tests typically include serological assays, which detect antibodies or antigens, and nucleic acid testing (NAT), which identifies viral genetic material and allows for earlier detection of infections, even before antibodies develop.

Beyond transfusion safety, blood screening is widely used in routine healthcare to assess overall health and identify conditions such as anemia, diabetes, high cholesterol, liver or kidney disorders, and autoimmune diseases. It is also used for prenatal testing, cancer screening, and monitoring chronic illnesses.

Blood screening helps in reducing the risk of transfusion-transmitted infections (TTIs) and ensures that only safe blood is used for medical procedures. It also promotes confidence in national blood transfusion services and public health systems.

Regulatory authorities such as the World Health Organization (WHO), U.S. FDA, and national health ministries set and monitor standards for blood screening practices. Continuous advancements in screening technology and automation have enhanced the sensitivity, accuracy, and speed of blood testing, making blood screening a cornerstone of both preventive and curative healthcare worldwide.

FutureWise Market Research has published a report that provides an insightful analysis of Blood Screening Market trends that are affecting the overall market growth.

Request a Free Sample @ https://www.futurewiseresearch.com/contact.aspx?rpt=5868&type=requestsample

Blood Screening Market Segmentation:

By Product and Service

  • Reagents and Kits
    • NAT Reagents and Kits
      • Enzymes and Polymerases
      • Standards and Controls
      • Probes and Primers
      • Buffers, Nucleotides, and Solutions
      • Labelling and Detection Reagents
    • ELISA Reagents and Kits
      • Immunosorbents
      • Controls
      • Conjugates
      • Substrates
      • Sample Diluents and Wash Solutions
    • Other Reagents and Kits
  • Instruments
    • Outright Purchase
    • Rental Purchase
  • Software and Services

By Technology

  • Nucleic Acid Testing
    • Transcription-Mediated Amplification
    • Real-time Polymerase Chain Reaction
  • Enzyme-Linked Immunosorbent Assay (ELISA)
    • Chemiluminescent Immunoassay
    • Fluorescent immunoassay
    • Colorimetric Immunoassay
  • Rapid Tests
  • Western Blot Assays
  • Next-Generation Sequencing (NGS)

By End User

  • Blood Banks
  • Hospitals

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Competitive Landscape in Blood Screening Market:

  • Grifols
  • F. Hoffmann-La Roche
  • Abbott Laboratories
  • Biomérieux
  • Bio-Rad Laboratories
  • Becton, Dickson and Company
  • Danaher Corporation
  • Ortho Clinical Diagnostics
  • Siemens Healthineers
  • Thermo Fisher Scientific
  • Diasorin
  • GE Healthcare
  • Merck KGaA
  • PerkinElmer
  • Bio-Techne

Buy now the latest version of this report: https://www.futurewiseresearch.com/checkout.aspx?ReportId=5868&license=multi

**Objectives of this Study: **

  1. To provide a comprehensive analysis of the Blood Screening Market By Product & Service, By Technology, By End User and By Region.
  2. To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
  3. To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
  4. To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

                                                                                                                
Flexible Delivery Model:

  • We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
  • The customization services offered are free of charge with the purchase of any license of the report.
  • You can directly share your requirements/changes to the current table of contents to: sales@futurewiseresearch.com